Two Sigma Securities »

TherapeuticsMD shares owned by Two Sigma Securities

Quarter-by-quarter ownership of TherapeuticsMD (TXMD) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in TherapeuticsMD

Tip: Access up to 7 years of quarterly data

All positions including TherapeuticsMD held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in TherapeuticsMD by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $23k 14k 1.61
2022-06-30 $103k 10k 9.93

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding TherapeuticsMD

Rubric Capital Management
Clearline Capital
Tejara Capital
Vanguard Group
Morgan Stanley
BlackRock
BlackRock
Geode Capital Management
Bridgeway Capital Management
State Street Corporation
Northern Trust
Two Sigma Securities
J. Goldman & Co
Citadel Advisors
Tower Research Capital

View all funds holding TherapeuticsMD